# iTBS-DCS in Fibromyalgia

> **NCT05395494** · PHASE2 · TERMINATED · sponsor: **University of Calgary** · enrollment: 47 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** D-Cycloserine
- **DRUG:** Placebo oral tablet
- **DEVICE:** iTBS repetitive Transcranial Magnetic Stimulation (rTMS)

## Key facts

- **NCT ID:** NCT05395494
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-29
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** Futility criteria met on interim analysis
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05395494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05395494, "iTBS-DCS in Fibromyalgia". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05395494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*